Analysis of the M1/M2 profiles demonstrated these microglia showed elevated M1 markers (Figure 5C), including MHCII, CD11c, and CD86, indicating that the microglia polarized toward to M1, which is beneficial for an anti-tumor effect. The gene discussed is CD86; the disease is neoplasm.